US Patent 10154983 Neurodegenerative disorders and muscle diseases implicating PUFAs
Patent 10154983 was granted and assigned to Retrotope Inc. on December, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+423 characters)
Article
Patent abstract
Some aspects of the invention provide for a method of treating Alzheimer's Disease, Mild Cognitive Impairment, Frontotemperal Dementia, Amyotrophic Lateral Sclerosis and/or Multiple Sclerosis using polyunsaturated fatty acids which are modified in certain positions to attenuate oxidative damage by Reactive Oxygen Species (ROS) and/or suppress the rate of formation of reactive products and toxic compounds.
Edits on 25 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
101549830
Date of Patent
December 18, 2018
0Patent Application Number
141135420
Date Filed
April 24, 2012
0Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
101549830
Date of Patent
December 18, 2018
0Patent Application Number
141135420
Date Filed
April 24, 2012
0Patent Primary Examiner
Edits on 24 Jan, 2022
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 10154983 Neurodegenerative disorders and muscle diseases implicating PUFAs
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
10154983
Date of patent
December 18, 2018
Patent application number
14113542
Date Filed
April 24, 2012
Patent primary examiner
Find more entities like US Patent 10154983 Neurodegenerative disorders and muscle diseases implicating PUFAs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
